Sabha Ganai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sabha Ganai has a total of 207 co-authors. Here are the top co-authors by number of shared publications:
John D. Mellinger
Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL
7 shared publicationsMitchell C. Posner
Department of Surgery, The University of Chicago, Chicago, IL 60637, USA
7 shared publicationsEmily C. Sturm
Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL
4 shared publicationsMark Talamonti
Department of Surgery, NorthShore University Hospital, Evanston, IL 60201, USA
4 shared publicationsNikolai N. Khodarev
Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA
4 shared publications- Ralph R. Weichselbaum
Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, USA
4 shared publications
Latest Publications
- 1 January 2022
- Published by Springer Nature
- p. 91-104
Goals of Care Discussions in High-Risk Surgery
- 1 January 2022
- Published by Springer Nature
- p. 105-119
The Ethics of Telehealth in Surgery
- 1 August 2019
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 270 (2) , 295-301
Survival Implications of Increased Utilization of Local Excision for cT1N0 Esophageal Cancer
We hypothesized that patients with cT1N0 esophageal cancer undergoing local excision would have lower survival compared with esophagectomy due to potential discordant staging. Local excision has become an attractive alternative for management of early esophageal cancer, avoiding the morbidity of esophagectomy. It is uncertain if occult nodal metastasis impacts survival. An observational study was conducted using the National Cancer Database (1998–2012) for patients with clinical T1N0 esophageal cancer who underwent local excision (n = 1625) or esophagectomy (n = 3255). The proportion of patients undergoing local excision increased from 12% in 1998 to 50% in 2012 (P < 0.001). After esophagectomy, 61% of cT1N0 cancers had concordant clinical and pathological staging, with 5.2% having positive nodal disease; 37% were staged concordant after local excision, with excess missing data (60%). Ninety-day mortality was 7.4% after esophagectomy compared with 2.8% after local excision (P < 0.001). While no significant difference was seen in unadjusted survival, adjusted Cox regression analysis indicated worse survival after esophagectomy compared with local excision for all cases [hazard ratio (HR) 1.57, 95% confidence interval (CI) 1.27–1.95] and for patients with concordant staging (HR 1.68, 95% CI 1.23–2.28). Local excision for cT1N0 esophageal cancer has increased over time. Contrary to our hypothesis, despite incomplete nodal staging, patients undergoing local excision have favorable survival, particularly in the adenocarcinoma subgroup. This may reflect early differences in mortality due to differences in procedure-related complications and/or selection bias. As this study has limited power to compare outcomes between T1a and T1b cancers, further analysis is warranted.
- 1 August 2019
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 270 (2) , 295-301
Survival Implications of Increased Utilization of Local Excision for cT1N0 Esophageal Cancer
We hypothesized that patients with cT1N0 esophageal cancer undergoing local excision would have lower survival compared with esophagectomy due to potential discordant staging. Local excision has become an attractive alternative for management of early esophageal cancer, avoiding the morbidity of esophagectomy. It is uncertain if occult nodal metastasis impacts survival. An observational study was conducted using the National Cancer Database (1998–2012) for patients with clinical T1N0 esophageal cancer who underwent local excision (n = 1625) or esophagectomy (n = 3255). The proportion of patients undergoing local excision increased from 12% in 1998 to 50% in 2012 (P < 0.001). After esophagectomy, 61% of cT1N0 cancers had concordant clinical and pathological staging, with 5.2% having positive nodal disease; 37% were staged concordant after local excision, with excess missing data (60%). Ninety-day mortality was 7.4% after esophagectomy compared with 2.8% after local excision (P < 0.001). While no significant difference was seen in unadjusted survival, adjusted Cox regression analysis indicated worse survival after esophagectomy compared with local excision for all cases [hazard ratio (HR) 1.57, 95% confidence interval (CI) 1.27–1.95] and for patients with concordant staging (HR 1.68, 95% CI 1.23–2.28). Local excision for cT1N0 esophageal cancer has increased over time. Contrary to our hypothesis, despite incomplete nodal staging, patients undergoing local excision have favorable survival, particularly in the adenocarcinoma subgroup. This may reflect early differences in mortality due to differences in procedure-related complications and/or selection bias. As this study has limited power to compare outcomes between T1a and T1b cancers, further analysis is warranted.
- 17 May 2019
- Published by Wiley in The Journal of Rural Health
- Vol. 36 (3) , 326-333
Impact of Rurality on National Trends in Thyroid Cancer Incidence and Long‐Term Survival
Purpose: Thyroid cancer incidence is rising, possibly secondary to increased imaging and surveillance. Based on rural access to care disparities, we hypothesized that incidence would be greater in urban compared to rural counties with no significant difference in long‐term survival.Methods: An observational study was performed on thyroid cancer patients using Surveillance Epidemiology and End Results data (2000‐2012). Age‐adjusted incidence rates, incidence rate ratios, and survival rates were calculated across rural‐urban designations.Findings: Incidence rates were 11.2, 9.8, and 10.1 per 100,000 for urban, rural‐adjacent, and rural‐nonadjacent counties, respectively. Statistically significantly lower incidence was noted in rural‐adjacent and rural‐nonadjacent compared to urban areas. Five‐year and 10‐year survival was significantly lower in rural‐nonadjacent counties compared to urban counties.Conclusions: Higher incidence and increased long‐term survival for thyroid cancer were noted in urban areas compared to rural areas. It is uncertain if rural‐urban differences in long‐term survival reflect health care disparities, differences in therapy, or other origins.
- 17 May 2019
- Published by Wiley in The Journal of Rural Health
- Vol. 36 (3) , 326-333
Impact of Rurality on National Trends in Thyroid Cancer Incidence and Long‐Term Survival
Purpose: Thyroid cancer incidence is rising, possibly secondary to increased imaging and surveillance. Based on rural access to care disparities, we hypothesized that incidence would be greater in urban compared to rural counties with no significant difference in long‐term survival.Methods: An observational study was performed on thyroid cancer patients using Surveillance Epidemiology and End Results data (2000‐2012). Age‐adjusted incidence rates, incidence rate ratios, and survival rates were calculated across rural‐urban designations.Findings: Incidence rates were 11.2, 9.8, and 10.1 per 100,000 for urban, rural‐adjacent, and rural‐nonadjacent counties, respectively. Statistically significantly lower incidence was noted in rural‐adjacent and rural‐nonadjacent compared to urban areas. Five‐year and 10‐year survival was significantly lower in rural‐nonadjacent counties compared to urban counties.Conclusions: Higher incidence and increased long‐term survival for thyroid cancer were noted in urban areas compared to rural areas. It is uncertain if rural‐urban differences in long‐term survival reflect health care disparities, differences in therapy, or other origins.
- 27 March 2019
- Published by Springer Nature
- p. 217-229
Informed Consent and Disclosure of Surgeon Experience
- 27 March 2019
- Published by Springer Nature
- p. 217-229
Informed Consent and Disclosure of Surgeon Experience
- 1 March 2019
- Published by Elsevier in Journal of Surgical Education
- Vol. 76 (2) , 378-386
National Trends in General Surgery Resident Exposure to Complex Oncology-Relevant Cases
- 1 March 2019
- Published by Elsevier in Journal of Surgical Education
- Vol. 76 (2) , 378-386
National Trends in General Surgery Resident Exposure to Complex Oncology-Relevant Cases
- Open Access
- 13 November 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 4827
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
In the originally published version of this Article, the affiliation details for Kevin P. White inadvertently omitted ‘Tempus Labs, Chicago, IL, 60654, USA’. This has now been corrected in both the PDF and HTML versions of the Article.
- 13 November 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 4827
Open AccessAuthor Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
In the originally published version of this Article, the affiliation details for Kevin P. White inadvertently omitted ‘Tempus Labs, Chicago, IL, 60654, USA’. This has now been corrected in both the PDF and HTML versions of the Article.
- Open Access
- 4 May 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-8
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
The oligometastasis hypothesis suggests a spectrum of metastatic virulence where some metastases are limited in extent and curable with focal therapies. A subset of patients with metastatic colorectal cancer achieves prolonged survival after resection of liver metastases consistent with oligometastasis. Here we define three robust subtypes of de novo colorectal liver metastasis through integrative molecular analysis. Patients with metastases exhibiting MSI-independent immune activation experience the most favorable survival. Subtypes with adverse outcomes demonstrateVEGFAamplification in concert with (i) stromal, mesenchymal, and angiogenic signatures, or (ii) exclusiveNOTCH1andPIK3C2Bmutations with E2F/MYC activation. Molecular subtypes complement clinical risk stratification to distinguish low-risk, intermediate-risk, and high-risk patients with 10-year overall survivals of 94%, 45%, and 19%, respectively. Our findings provide a framework for integrated classification and treatment of metastasis and support the biological basis of curable oligometastatic colorectal cancer. These concepts may be applicable to many patients with metastatic cancer.
- 4 May 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-8
Open AccessIntegrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis
The oligometastasis hypothesis suggests a spectrum of metastatic virulence where some metastases are limited in extent and curable with focal therapies. A subset of patients with metastatic colorectal cancer achieves prolonged survival after resection of liver metastases consistent with oligometastasis. Here we define three robust subtypes of de novo colorectal liver metastasis through integrative molecular analysis. Patients with metastases exhibiting MSI-independent immune activation experience the most favorable survival. Subtypes with adverse outcomes demonstrateVEGFAamplification in concert with (i) stromal, mesenchymal, and angiogenic signatures, or (ii) exclusiveNOTCH1andPIK3C2Bmutations with E2F/MYC activation. Molecular subtypes complement clinical risk stratification to distinguish low-risk, intermediate-risk, and high-risk patients with 10-year overall survivals of 94%, 45%, and 19%, respectively. Our findings provide a framework for integrated classification and treatment of metastasis and support the biological basis of curable oligometastatic colorectal cancer. These concepts may be applicable to many patients with metastatic cancer.